Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
16 hedge funds and large institutions have $1.61M invested in Bio-Path Holdings Inc in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 0 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
7% more funds holding
Funds holding: 15 → 16 (+1)
23% less capital invested
Capital invested by funds: $2.1M → $1.61M (-$486K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$361K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$184K |
| 3 |
BlackRock
New York
|
+$24.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$12.5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$8.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$19K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $694K | +$184K | +1,548 | +25% |
|
|
2
BlackRock
New York
| $313K | +$24.3K | +205 | +6% |
|
|
3
Renaissance Technologies
New York
| $274K | +$361K | +3,042 | New |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $164K | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| $92K | – | – | – |
|
6
Bank of Montreal
Toronto,
Ontario, Canada
| $46K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $9K | +$12.5K | +105 | New |
|
|
8
Morgan Stanley
New York
| $8K | -$19K | -160 | -64% |
|
|
9
Bank of America
Charlotte,
North Carolina
| $6K | +$8.07K | +68 | +6,800% |
|
|
PA
10
Procyon Advisors
Shelton,
Connecticut
| $5K | – | – | – |
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$356 | +3 | +100% |
|
12
Wells Fargo
San Francisco,
California
| – | +$119 | +1 | +50% |
|
BPTH Hedge Fund Activity: Q1 2020 in Review
16 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2020, worth a combined $1.61M — down 23% from $2.1M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BPTH positions and 0 closed out — a net gain of 2 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $361K. The largest seller was Morgan Stanley, cutting an estimated $19K.
- 16 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2020, up from 15 in Q4 2019.
- Funds reported $1.61M of Bio-Path Holdings Inc stock for Q1 2020, down 23% quarter-over-quarter.
- 2 funds opened new Bio-Path Holdings Inc positions in Q1 2020 and 0 closed out, a net change of +2 holders.
- The largest Bio-Path Holdings Inc buyer in Q1 2020 was Renaissance Technologies, an estimated $361K added.
- The largest Bio-Path Holdings Inc seller in Q1 2020 was Morgan Stanley, an estimated $19K sold.
Based on aggregated 13F filings for Q1 2020.